A report recently issued by Deloitte Access Economics (commissioned by Asthma Australia and the National Asthma Council Australia) details the financial impact of asthma in Australia. The report (see here) is extremely comprehensive.
Some of the key points in the report are as follows:
- There is estimated to be 2.4 million Australians with asthma in 2015
- The prevalence of asthma in Australia is around 10%
- Australia has the second highest prevalence of asthma among OECD countries – New Zealand has the highest at 14% and Korea the lowest at 1%
- Australia’s high prevalence of asthma may be due to the variability of weather in Australia and the high prevalence of allergenic risk factors, including natural events such as thunderstorms and winds that distribute allergenic pollen, grasses and particles
- The direct healthcare costs of asthma in Australia total $1.2 billion.
Some interesting food for thought for nurses.